Liver mass evaluation with ultrasound: The impact of microbubble contrast agents and pulse inversion imaging

Seminars in Liver Disease

Volumn 21, Issue 2, 2001, Pages 147-159

  Wilson, S R ^a   Burns, P N ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Contrast agents; Liver; Neoplasm; Pulse inversion imaging; Ultrasound

Indexed keywords

ECHO CONTRAST MEDIUM; FLUOROCARBON; FS 069; NC 100100; PERFLUTREN; SHU 508; SONOVUE; UNCLASSIFIED DRUG;

ARTICLE; CONTRAST ENHANCEMENT; HEMANGIOMA; HUMAN; IMAGING SYSTEM; LIVER CELL CARCINOMA; LIVER INJURY; LIVER METASTASIS; LIVER PARENCHYMA; LIVER TUMOR; NODULAR HYPERPLASIA; PRIORITY JOURNAL; TECHNIQUE; ULTRASOUND;

CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; GASES; HEMANGIOMA; HUMANS; IMAGE ENHANCEMENT; LIVER NEOPLASMS; ULTRASONOGRAPHY, DOPPLER;

EID: 0034967707     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-15342     Document Type: Article

References (16)

1. Microbubble destruction is the origin of harmonic signals from FS069
2. Harmonic imaging: A new imaging and Doppler method for contrast enhanced ultrasound
3. Harmonic imaging: Principles and preliminary results
4. Pulse inversion Doppler: A new method for detecting nonlinear echoes from microbubble contrast agents
5. Nonlinear imaging
6. Pulse inversion imaging of liver blood flow: An improved method for characterization of focal masses with microbubble contrast
7. Harmonic hepatic ultrasound with microbubble contrast agent: Initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis
8. Hepatic tumors: Contrast agent-enhancement patterns with pulse-inversion harmonic US
9. Real-time contrast echo assessment of myocardial perfusion at low emission power: First experimental and clinical results using power pulse inversion imaging
10. Contrast agents in diagnostic ultrasound
11. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: Preliminary results
12. Focal liver masses: Interpreting patterns of enhancement with Levovist and pulse inversion imaging
13. Sonographic evaluation of focal nodular hyperplasia (FNH) of the liver with a transpulmonary contrast agent (Levovist)
14. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: Early experience
15. Improved detection of metastic liver lesions using pulse inversion harmonic imaging with Levovist: A multicenter study